News Biofrontera AG

Equities

B8FK

DE000A4BGGM7

End-of-day quote Xetra Other stock markets 06:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
2.945 ^EUR	+1.38%		-1.67%	-65.03%

Jun. 24	Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	CI
May. 31	Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	Jun. 24	CI
Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 31	CI
Biofrontera : Quarterly Report 1st Quarter Q1/2024	May. 31	PU
Biofrontera : RULES OF PROCEDURE of the Supervisory Board	May. 26	PU
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	May. 15	MT
Biofrontera : Subscription offer (CONVENIENCE TRANSLATION)	May. 14	PU
Reverse Split: 1 of 21; Rights Issue: 1 new share @ 1.1 EUR of 1 existing share	May. 13	FA
Rights Issue: 1 new share @ 1.1 EUR for 1 existing share	May. 13	FA
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	Mar. 11	MT
Medicus Pharma Names COO	Mar. 05	MT
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	Feb. 21	AQ
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	Feb. 21	AQ
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $8.9M, vs. Street Est of $8.4M	Nov. 09	MT
Biofrontera Licensor Gets FDA Approval for New Formulation of Ameluz to Treat Actinic Keratosis	23-10-10	MT
Biofrontera Says Sun Pharmaceutical Alleging Breach of Contract In Lawsuit	23-10-03	DJ
Biofrontera AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Biofrontera Says Skin Disease Therapy Was Well-Tolerated in Phase 1 Safety Trial	23-08-28	MT
Earnings Flash (BFRI) BIOFRONTERA Reports Q2 Revenue $5.8M	23-08-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biofrontera AG

Equities

B8FK

DE000A4BGGM7

Summary

Filters